1. Home
  2. EHC vs TWST Comparison

EHC vs TWST Comparison

Compare EHC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

HOLD

Current Price

$122.00

Market Cap

11.2B

Sector

Health Care

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

N/A

Current Price

$137.85

Market Cap

9.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EHC
TWST
Founded
1983
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
9.2B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
EHC
TWST
Price
$122.00
$137.85
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$143.29
$46.88
AVG Volume (30 Days)
739.5K
1.5M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
0.74%
N/A
EPS Growth
24.22
63.89
EPS
3.47
N/A
Revenue
N/A
$376,572,000.00
Revenue This Year
$9.33
$18.91
Revenue Next Year
$8.14
$15.07
P/E Ratio
$35.07
N/A
Revenue Growth
N/A
20.32
52 Week Low
$92.77
$23.30
52 Week High
$127.99
$155.44

Technical Indicators

Market Signals
Indicator
EHC
TWST
Relative Strength Index (RSI) 59.01 56.62
Support Level $118.77 $38.64
Resistance Level $127.50 $155.44
Average True Range (ATR) 2.33 8.92
MACD -0.30 -2.45
Stochastic Oscillator 68.64 42.13

Price Performance

Historical Comparison
EHC
TWST

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: